The bioavailability and bioequivalence centre is offering comprehensive range of services to the various leading Generic, Pharmaceutical and Biotech industries in line with the global regulatory requirements to support the needs of the clinical research during the product development stage for their regulatory submissions.
The centre is approved by DCGI and conducting the studies by implementing stringent GLP/GCP practices. Our team of experienced clinical pharmacokineticists offers unsurpassed innovation and expertise in conducting clinical PK/PD studies and capable of performing multiple studies simultaneously in quick turnaround time.
Our reputation, excellent quality, on time delivery, with personalized service has earned us exceptional customer loyalty.